Trial Profile
A Double-blind Randomised Controlled Trial Investigating the Most Efficacious Dose of Botulinum Toxin-A for Sialorrhoea Treatment in Asian Adults With Neurological Diseases
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 31 May 2019
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Sialorrhoea
- Focus Therapeutic Use
- 27 Apr 2015 New trial record